Heron Therapeutics
HRTX
HRTX
141 hedge funds and large institutions have $122M invested in Heron Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 41
5% less funds holding
Funds holding: 149 → 141 (-8)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
Holders
141
Holding in Top 10
3
Calls
$1.38M
Puts
$16K
Top Buyers
| 1 | +$15.4M | |
| 2 | +$3.59M | |
| 3 | +$2.56M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.03M |
| 5 |
OCM
Orchard Capital Management
Chicago,
Illinois
|
+$774K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$791K | |
| 3 | -$515K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$473K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$438K |